Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Commentary: Sorafenib use in patients with advanced hepatocellular carcinoma and underlying Child-Pugh B cirrhosis: evidence and controversy.

× No keyword cloud information.

6 in total

1. Targeted therapies: Role of sorafenib in HCC patients with compromised liver function.

Authors: Massimo Di Maio; Bruno Daniele; Francesco Perrone
Journal: Nat Rev Clin Oncol Date: 2009-09 Impact factor: 66.675

2. Antitumor activity of sphingosine kinase 2 inhibitor ABC294640 and sorafenib in hepatocellular carcinoma xenografts.

Authors: Vladimir Beljanski; Clayton S Lewis; Charles D Smith
Journal: Cancer Biol Ther Date: 2011-03-01 Impact factor: 4.742

3. Long-term clinical outcomes of hepatic arterial infusion chemotherapy with cisplatin with or without 5-fluorouracil in locally advanced hepatocellular carcinoma.

Authors: Beom Kyung Kim; Jun Yong Park; Hye Jin Choi; Do Young Kim; Sang Hoon Ahn; Ja Kyung Kim; Do Youn Lee; Kwang Hoon Lee; Kwang-Hyub Han
Journal: J Cancer Res Clin Oncol Date: 2010-06-16 Impact factor: 4.553

Review 4. Methodological assessment of HCC literature.

Authors: G Daniele; N Costa; V Lorusso; J Costa-Maia; I Pache; M Pirisi
Journal: Ann Oncol Date: 2013-04 Impact factor: 32.976

5. Regorafenib treatment for patients with hepatocellular carcinoma who progressed on sorafenib-A cost-effectiveness analysis.

Authors: Amir Shlomai; Moshe Leshno; Daniel A Goldstein
Journal: PLoS One Date: 2018-11-08 Impact factor: 3.240

6. Sorafenib inhibits macrophage-mediated epithelial-mesenchymal transition in hepatocellular carcinoma.

Authors: Yan-Ru Deng; Wen-Bin Liu; Zhe-Xiong Lian; Xingsheng Li; Xin Hou
Journal: Oncotarget Date: 2016-06-21

6 in total